Skip to main content
. 2012 Apr 1;13(6):358–368. doi: 10.4161/cbt.19241

Table 1. AdoMetDC activity, AdoMet and dcAdoMet content in TPA-treated wild type and CAG-SpmS mice.

Tissue Group Time after TPA (h) AdoMetDC activity
(pmol CO2/30 min/mg protein)
AdoMet
(pmol/mg tissue)
dcAdoMet
(pmol/mg tissue)
Epidermis
Wild type
0
49 ± 24
7.3 ± 2.0
0.081 ± 0.012
 
24
202 ± 158e
18.0 ± 3.9h
0.321 ± 0.288
 
 
48
424 ± 237g
20.6 ± 10.5f
0.335 ± 0.190g
 
CAG-SpmS
0
75 ± 18a
11.9 ± 3.2a
0.048 ± 0.036a
 
 
24
142 ± 65e
20.5 ± 6.9
0.054 ± 0.035a
 
 
48
281 ± 118g
18.4 ± 4.9
0.087 ± 0.041c
 
 
 
 
 
 
Dermis
Wild type
0
44 ± 22
7.2 ± 2.1
0.103 ± 0.033
 
 
24
99 ± 18h
10.2 ± 2.3e
0.082 ± 0.014
 
 
48
129 ± 76e
11.3 ± 2.9g
0.087 ± 0.020
 
CAG-SpmS
0
44 ± 12
6.7 ± 3.1
0.095 ± 0.028
 
 
24
76 ± 10b,h
10.7 ± 1.4
0.018 ± 0.004d,g
    48 90 ± 43e 9.2 ± 3.2 0.017 ± 0.007c,e

AdoMetDC enzymatic activity as well as AdoMet and dcAdoMet content were determined in 7 to 9-week-old mice. Values represent mean ± SD of 4 to 8 mice. ap < 0.05 vs. wild type at the same time; bp < 0.01 vs. wild type at the same time; cp < 0.005 vs. wild type at the same time; dp < 0.001 vs. wild type at the same time; ep < 0.05 vs. 0h of the same genotype; fp < 0.01 vs. 0h of the same genotype; gp < 0.005 vs. 0h of the same genotype; hp < 0.001 vs. 0h of the same genotype.